Hackensack Meridian Health’s iShares MSCI ACWI ETF ACWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Buy
148,000
+63,000
+74% +$9.62M 1.57% 7
2026
Q1
$11.8M Hold
85,000
1.11% 7
2025
Q4
$12M Hold
85,000
1.1% 7
2025
Q3
$11.8M Hold
85,000
1.21% 6
2025
Q2
$10.9M Sell
85,000
-555,000
-87% -$66.5M 1.21% 6
2025
Q1
$74.5M Sell
640,000
-330,000
-34% -$39.5M 8.48% 6
2024
Q4
$114M Hold
970,000
13.54% 4
2024
Q3
$116M Sell
970,000
-460,000
-32% -$52.7M 11.91% 4
2024
Q2
$161M Hold
1,430,000
21.43% 2
2024
Q1
$157M Buy
+1,430,000
New +$150M 21.17% 2
2022
Q4
Sell
-1,195,000
Closed -$93M 8
2022
Q3
$93M Hold
1,195,000
12.71% 3
2022
Q2
$100M Buy
1,195,000
+245,000
+26% +$22.3M 11.15% 3
2022
Q1
$94.8M Buy
+950,000
New +$94.7M 9.89% 5

Other funds holding ACWI

Hackensack Meridian Health's ACWI Position: Q2 2026 in Review

Hackensack Meridian Health increased its iShares MSCI ACWI ETF (ACWI) stake by 74% in Q2 2026, buying an estimated $9.62M and bringing the position to 148,000 shares worth $23.2M. The position accounts for 1.57% of the portfolio, ranked #7.

Hackensack Meridian Health first reported a position in ACWI in Q1 2022 and has held it in 13 quarters since. The position peaked at $161M in Q2 2024. 840 funds tracked by Wall St. Rank hold ACWI as of Q2 2026.

  • Hackensack Meridian Health held 148,000 shares of iShares MSCI ACWI ETF worth $23.2M as of Q2 2026.
  • Hackensack Meridian Health bought 63,000 iShares MSCI ACWI ETF shares in Q2 2026, an estimated $9.62M.
  • iShares MSCI ACWI ETF made up 1.57% of Hackensack Meridian Health's portfolio in Q2 2026, its #7 holding.
  • Hackensack Meridian Health first reported a position in iShares MSCI ACWI ETF in Q1 2022 and has held it in 13 quarters since.
  • Hackensack Meridian Health's iShares MSCI ACWI ETF position peaked at $161M in Q2 2024.
  • 840 funds tracked by Wall St. Rank held iShares MSCI ACWI ETF as of Q2 2026.

Based on Hackensack Meridian Health's 13F filing for Q2 2026, filed 5 Aug 2026.